Sorted By Test Name - Mayo Medical Laboratories

AMT
8125
AFC
80334
clinicians who treat patients with amiodarone. Heart Rhythm 2007;4:1250-1259 2. Klotz U:
Antiarrhythmics: elimination and dosage considerations in hepatic impairment. Clin
Pharmacokinet.2007;46(12):985-996 3. Campbell TJ, Williams KM: Therapeutic drug monitoring:
antiarrhythmic drugs. Br J Clin Pharmacol.2001;52 Suppl1:21S-34S
Amitriptyline and Nortriptyline, Serum
Clinical Information: Amitriptyline is a tricyclic antidepressant that is metabolized to nortriptyline,
which has similar pharmacologic activity. The relative blood levels of amitriptyline and nortriptyline are
highly variable among patients. Amitriptyline is the drug of choice in treatment of depression when the
side effect of mild sedation is desirable. Nortriptyline is used when its stimulatory side effect is
considered to be of clinical advantage. Amitriptyline displays major cardiac toxicity when the
concentration of amitriptyline and nortriptyline is in excess of 300 ng/mL, characterized by QRS
widening leading to ventricular tachycardia and asystole. In some patients, toxicity may manifest at lower
concentrations. Nortriptyline is unique among the antidepressants in that its blood level exhibits the
classical therapeutic window effect; blood concentrations above or below the therapeutic window
correlate with poor clinical response. Thus, therapeutic monitoring to ensure that the blood level is within
the therapeutic window is critical to accomplish successful treatment with this drug. Like amitriptyline,
nortriptyline can cause major cardiac toxicity when the concentration is in excess of 300 ng/mL,
characterized by QRS widening leading to ventricular tachycardia and asystole. In some patients, toxicity
may manifest at lower concentrations.
Useful For: Monitoring serum concentration during therapy Evaluating potential toxicity The test may
also be useful to evaluate patient compliance
Interpretation: Most individuals display optimal response to amitriptyline when combined serum
levels of amitriptyline and nortriptyline are between 80 and 200 ng/mL. Risk of toxicity is increased with
combined levels > or =300 ng/mL. Most individuals display optimal response to nortriptyline with serum
levels between 70 and 170 ng/mL. Risk of toxicity is increased with nortriptyline levels > or =300 ng/mL.
Some individuals may respond well outside of these ranges, or may display toxicity within the therapeutic
range, thus interpretation should include clinical evaluation. Therapeutic ranges are based on specimens
drawn at trough (ie, immediately before the next dose).
Reference Values:
AMITRIPTYLINE AND NORTRIPTYLINE
Total therapeutic concentration: 80-200 ng/mL
Total toxic concentration: > or =300 ng/mL
NORTRIPTYLINE ONLY
Therapeutic concentration: 70-170 ng/mL
Toxic concentration: > or =300 ng/mL
Note: Therapeutic ranges are for specimens drawn at trough (ie, immediately before next scheduled
dose). Levels may be elevated in non-trough specimens.
Clinical References: 1. Wille SM, Cooreman SG, Neels HM, Lambert WE: Relevant issues in the
monitoring and the toxicology of antidepressants. Crit Rev Clin Lab Sci 2008;45(1):25-89 2. Thanacoody
HK, Thomas SH: Antidepressant poisoning. Clin Med 2003;3(2):114-118 3. Baumann P, Hiemke C,
Ulrich S, et al: The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in
psychiatry. Pharmacopsychiatry 2004;37(6):243-265
Amniotic Fluid Culture for Genetic Testing
Clinical Information: Fetal cells obtained by amniocentesis (amniocytes) are used for a wide range
of laboratory tests. Prior to testing, the cells may need to be cultured to obtain adequate numbers of
amniocytes.
Useful For: Producing amniocyte cultures that can be used for genetic analysis Once confluent flasks
Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or MayoMedicalLaboratories.com Page 121